Jianfeng Xu

Phase I evaluation of pharmacokinetics and tolerability of the HIV‐1 maturation inhibitor GSK3640254 and dolutegravir in healthy adults

Samit R. Joshi, Mark Johnson, M. Lataillade, 2021, British journal of clinical pharmacology.

A Phase I Evaluation of the Pharmacokinetics and Tolerability of the HIV-1 Maturation Inhibitor GSK3640254 and Tenofovir Alafenamide/Emtricitabine in Healthy Participants

Samit R. Joshi, Mark Johnson, M. Lataillade, 2021, Antimicrobial Agents and Chemotherapy.

Phase I evaluation of the safety, tolerability, and pharmacokinetics of GSK3640254, a next‐generation HIV‐1 maturation inhibitor

Samit R. Joshi, A. S. Krishnatry, G. Ferron-Brady, 2020, Pharmacology research & perspectives.

A Phase IIa Study Evaluating Safety, Pharmacokinetics, and Antiviral Activity of GSK2838232, a Novel, Second-generation Maturation Inhibitor, in Participants With Human Immunodeficiency Virus Type 1 Infection.

M. Ramgopal, E. Dejesus, E. Dumont, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The safety, tolerability, and pharmacokinetic profile of GSK2838232, a novel 2nd generation HIV maturation inhibitor, as assessed in healthy subjects

S. Baldwin, M. Davies, Mark Johnson, 2018, Pharmacology research & perspectives.

Lack of pharmacokinetic interaction between the HIV‐1 maturation inhibitor GSK3640254 and combination oral contraceptives in healthy women

Samit R. Joshi, Mark Johnson, M. Lataillade, 2021, British Journal of Clinical Pharmacology.

Evaluation of the safety, pharmacokinetics, pharmacodynamics, and drug-drug interaction potential of a selective Lp-PLA2 inhibitor (GSK2647544) in healthy volunteers

Yanmei Xu, A. Lockhart, X. Yao, 2016, International journal of clinical pharmacology and therapeutics.

Safety, pharmacokinetics, pharmacodynamics, and bioavailability of GSK2018682, a sphingosine‐1‐phosphate receptor modulator, in healthy volunteers

Jiansong Yang, Jianfeng Xu, F. Gray, 2014, Clinical pharmacology in drug development.

An adaptive design to investigate the effect of ketoconazole on pharmacokinetics of GSK239512 in healthy male volunteers

Yanmei Xu, G. Collins, R. Mohindra, 2015, Journal of clinical pharmacology.

Phase IIa Proof-of-Concept Evaluation of the Antiviral Efficacy, Safety, Tolerability, and Pharmacokinetics of the Next-Generation Maturation Inhibitor GSK3640254

Samit R. Joshi, C. Spinner, C. Stephan, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.